Home/Filings/4/0000875320-09-000008
4//SEC Filing

GARRISON RICHARD C 4

Accession 0000875320-09-000008

CIK 0000875320other

Filed

Feb 5, 7:00 PM ET

Accepted

Feb 6, 4:23 PM ET

Size

8.0 KB

Accession

0000875320-09-000008

Insider Transaction Report

Form 4
Period: 2009-02-05
GARRISON RICHARD C
SVP and Catalyst
Transactions
  • Award

    Stock Option

    2009-02-05+45,75045,750 total
    Exercise: $33.55From: 2009-05-05Exp: 2019-02-04Common Stock (45,750 underlying)
  • Award

    Common Stock

    2009-02-05$0.01/sh+10,166$10237,437 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    799
Footnotes (2)
  • [F1]Stock grant made under 2006 Stock and Option Plan, vesting on 2/5/2013, subject to 50% acceleration upon filing a new drug application with the FDA for telaprevir and 50% acceleration upon the approval of a new drug application for telaprevir.
  • [F2]Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 02/05/09.

Issuer

VERTEX PHARMACEUTICALS INC / MA

CIK 0000875320

Entity typeother

Related Parties

1
  • filerCIK 0001256466

Filing Metadata

Form type
4
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 4:23 PM ET
Size
8.0 KB